Ethical Aspects
RESOLUTION
This study complies with Resolution 466/12, using a consent instrument (Opinion
2,404,143, approved in 2017) registered on the Brazilian Clinical Trial Registry
(ReBEC) platform, under protocol RBR-nº993xf7.